TREATMENT OF ABDOMINAL ATTACKS OF HEREDITARY ANGIOEDEMA WITH ECALLANTIDE

被引：0
|
作者：
Sheffer, A. L.
Lembo, A. J.
Stolz, L. E.
Stevens, C.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2012年 / 109卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：A124 / A124
页数：1
相关论文
共 50 条
  • [31] Hereditary angioedema: On-demand treatment of angioedema attacks
    Christiansen, Sandra C.
    Zuraw, Bruce L.
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2020, 41 : S26 - S29
  • [32] FDA Approves Ecallantide (Kalbitor) for Hereditary Angioedema
    不详
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (05) : 573 - 573
  • [33] Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency
    Rubinstein, Eitan
    Stolz, Leslie E.
    Sheffer, Albert L.
    Stevens, Chris
    Bousvaros, Athos
    [J]. BMC GASTROENTEROLOGY, 2014, 14
  • [34] Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency
    Eitan Rubinstein
    Leslie E Stolz
    Albert L Sheffer
    Chris Stevens
    Athos Bousvaros
    [J]. BMC Gastroenterology, 14
  • [35] A Case of Hereditary Angioedema Involving Recurrent Abdominal Attacks
    Kasamatsu, Yoshihiro
    Yoshinoya, Kiyokazu
    Kasamatsu, Yu
    Yamamoto, Tetsuro
    Horiuchi, Takahiko
    Kadoya, Masatoshi
    [J]. INTERNAL MEDICINE, 2011, 50 (23) : 2911 - 2914
  • [36] Rebound or relapse rates in hereditary angioedema attacks treated with ecallantide in an open-label, repeat-treatment study
    Soteres, D.
    MacGinnitie, A.
    Craig, T.
    Bernstein, J.
    Lumry, W.
    Li, H.
    Riedl, M.
    Iarrobino, R.
    Chyung, Y.
    Shea, E.
    Pullman, W.
    [J]. ALLERGY, 2012, 67 : 138 - 138
  • [37] Ecallantide Reverses Laryngeal Hereditary Angioedema Attacks: Experience from the EDEMA Clinical Development Program
    Sheffer, A. L.
    MacGinnitie, A. J.
    Campion, M.
    Stolz, L. E.
    Pullman, W. E.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB219 - AB219
  • [38] Response to ecallantide treatment of acute attacks of hereditary angioedema based on time to intervention: Results from the EDEMA clinical trials
    Banta, Erin
    Horn, Patrick
    Craig, Timothy J.
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2011, 32 (04) : 319 - 324
  • [39] Hypersensitivity Reactions to Ecallantide: an Update of the Clinical Trial Experience and Post-Market Surveillance for Treatment of Attacks of Hereditary Angioedema
    Craig, T. J.
    Riedl, M.
    Li, H. H.
    Bernstein, J. A.
    MacGinnitie, A. J.
    Soteres, D. F.
    Lumry, W. R.
    Pullman, W. E.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB220 - AB220
  • [40] Incidence of anti-ecallantide and neutralizing antibody formation in continuation-the open-label, extension study of ecallantide for the treatment of acute attacks of hereditary angioedema
    Lumry, W.
    Li, H.
    Stolz, L.
    [J]. ALLERGY, 2011, 66 : 80 - 81
12345